Author:
Schwarz Roy D.,Callahan Michael J.,Davis Robert E.,Emmerling Mark R.,Jaen Juan C.,Lipinski William,Pugsley Thomas A.,Raby Charlotte,Spencer Carolyn J.,Spiegel Katharyn,Tecle Haile,Brann Mark R.
Reference11 articles.
1. Bartus RT, Dean RL, Beer B and Lippa AS (1982): The cholinergic hypothesis of geriatric memory dysfuction. Science 217:408–416.
2. Braunner-Osborne H, Ebert B, Brann MR, Falch E, and Krogsgaard-Larsen P (1995): Annulated heterocyclic bioisosteres of norarecoline. Synthesis and molecular pharmacology at five recombinant human acetylcholine receptors. J Med Chem 38:2188–2195.
3. Davis RE, Doyle PD, Carroll RT, Emmerling MW, and Jaen J (1995): Cholinergic therapies for Alzheimer’s disease. Palliative or disease altering? Arzneim Forsh/Drug Res 45:425–431.
4. Dorje F, Levey AI, and Brann MR (1991): Immunological detection of muscarinic receptor subtype proteins (m1—m5) in rabbit peripheral tissues. Mol Pharmacol 40:459–462.
5. Jaen J, Barrett S, Brann M, Callahan M, Davis R, Doyle P, Eubanks D, Lauffer D, Lauffer L, Moreland D, Nelson C, Raby C, Schwarz R, Spencer C, and Tecle H (1995): In vitro and in vivo evaluation of the subtype selective muscarinic agonist PD 151832. Life Sci 56:845–852.